Clik here to view.
PeptiDream Announces Collaboration and License Agreement with Lilly to...
TOKYO PeptiDream Inc, a Tokyo-based biopharmaceutical company (PeptiDream)(TOKYO:4587), announced that they have entered into a Collaboration and License Agreement with US-based Eli Lilly and...
View ArticleClik here to view.
DxTerity’s REDI-Dx Wins 2013 NCT CBRNe Product of the Year Award
LOS ANGELES DxTerity Diagnostics announced that REDI-Dx™, the company’s blood-based gene expression test for estimating individualized levels of radiation exposure,* was named the 2013 NCT CBRNe...
View ArticleClik here to view.
CARMAT的生物假体人工心脏首次植入人体
巴黎 (美国商业资讯) –CARMAT (Paris:ALCAR) (FR0010907956, ALCAR)是世界上最先进的全人工心脏课题的设计者和开发者, 为罹患终末期心力衰竭的人士提供另一种医疗选择。该公司宣布，依据ANSM（法国卫生部国家药品及保健产品安全署）和个人保护委员会（伦理委员会）颁发的批复，公司的人工心脏已在一项可行性研究中首次植入人体。...
View ArticleClik here to view.
Tree Nut Consumption Associated with Reduced Total and Cause-Specific Mortality
Smart Multimedia Gallery American-grown pistachios (Photo: Business Wire) View and Share Photo Download Small FRESNO, Calif. In a study published November 20, 2013 in the New England Journal of...
View ArticleClik here to view.
世界初のMEVION S250による陽子線治療をバーンズ・ジューイッシュ病院で実施
Smart Multimedia Gallery View of the MEVION S250 Proton Therapy System treatment room at the Siteman Cancer Center at Barnes-Jewish Hospital in St. Louis, MO. (Photo: Business Wire) View and Share...
View ArticleClik here to view.
Menicon, Azabu University, and Yokohama City University Identify the Glaucoma...
NAGOYA, Japan Menicon announces that an article entitled, “Dogs and humans share a common susceptibility gene SRBD1 for glaucoma risk”, which presents the results of a study conducted by Menicon,...
View ArticleClik here to view.
カルマトのバイオプロテーゼ人工心臓を初めてヒトに移植
パリ （ビジネスワイヤ） — 世界最先端の完全人工心臓プロジェクトを設計・開発し、末期心不全を患う人々に代替法を提供しているカルマト（Paris:ALCAR）（FR0010907956,...
View ArticleClik here to view.
Menicon、麻布大学和横滨市立大学发现犬类青光眼易感基因SRBD1
日本名古屋 (美国商业资讯)–Menicon宣布，一篇题为“犬类的青光眼风险易感基因SRBD1与人类相同”的论文已发表于科学期刊PLoS ONE，该论文呈报了Menicon、麻布大学和横滨市立大学开展的一项研究（以下称“该研究”）的结果。 Menicon与麻布大学和横滨市立大学合作开展的研究发现，日本柴犬的青光眼易感基因与人类相同。...
View ArticleClik here to view.
European Medicines Agency (EMA) Accepts Otsuka’s Marketing Authorisation...
TOKYO Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted the submission of a marketing authorisation application (MAA) for the potential approval...
View ArticleClik here to view.
大塚製薬: 治療薬の無い、腎臓の希少疾病ADPKDへの取り組み自社開発薬「トルバプタン」欧州EMAが承認申請を受理
東京 （ビジネスワイヤ） — 大塚製薬株式会社（本社：東京都千代田区、代表取締役社長：岩本 太郎、以下「大塚製薬」）が、欧州における常染色体優性多発性嚢胞腎（ADPKD）の治療薬「トルバプタン」（一般名）として欧州医薬品庁（EMA*3）に提出した医薬品販売承認申請（MAA*4）が受理されました。...
View ArticleClik here to view.
Potential Safety Issue Identified in Counterfeit Pax from China
SAN FRANCISCO Ploom, inventors and manufacturers of first-in-category premium vaporizers, wishes to inform the public of a potential safety issue identified in counterfeit Pax vaporizers. Pax...
View ArticleClik here to view.
Tree Nut Consumption Associated with Reduced Total and Cause-Specific Mortality
Smart Multimedia Gallery American-grown pistachios (Photo: Business Wire) View and Share Photo Download Small FRESNO, Calif. In a study published November 20, 2013 in the New England Journal of...
View ArticleClik here to view.
Taro Announces Final Results of Its Self-Tender Offer
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced the final results of its modified “Dutch auction” tender offer to repurchase up to $200...
View ArticleClik here to view.
RxAdvance Deploys a Patent-Pending Innovative Service “Donut Hole Predictor &...
SOUTHBOROUGH, Mass. According to NEHI, prescription non-adherence is costing the US healthcare system $290B annually. Over 15% of the Medicare beneficiaries reach the prescription coverage gap or...
View ArticleClik here to view.
radioACTIVE inc. Releases “Sectional Walker”, an Interactive CT and MRI...
TOKYO radioACTIVE inc. has brought an ultimate solution to CT / MRI cross-sectional anatomy for iOS users. While touch tablets made things convenient and portable, learning anatomy is not an...
View ArticleClik here to view.
Navidea Biopharmaceuticals Expands Lymphoseek® Global Commercialization Efforts
DUBLIN, Ohio Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today it has entered into a distribution...
View ArticleClik here to view.
EPIRUS and Ranbaxy Announce Signing of BOW015 Licensing Partnership For Broad...
ZUG, Switzerland & NEW DELHI, India EPIRUS Switzerland GmbH, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, Inc. (“EPIRUS”), and Ranbaxy Laboratories Limited (“RANBAXY”) a...
View ArticleClik here to view.
Shanghai to Host 2014 Global Healthy Workplace Awards, Summit Sponsored by Cigna
SHANGHAI & BLOOMFIELD, Conn. Shanghai will host the second Global Healthy Workplace Awards and Summit April 9-10, 2014 as the search continues for the programs making the biggest impact on the...
View ArticleClik here to view.
由信诺集团赞助的2014年全球健康职场大奖峰会花落上海
上海将于 (美国商业资讯)– 年4月9~10日主办第二届全球健康职场大奖峰会，继续寻求为职场人士带来更多健康和福祉的各种方案。相关会议将在上海新天地安达仕酒店举行。...
View ArticleClik here to view.
東芝半導体セミナー「ビギナーのための半導体講座」の開催について
東京 （ビジネスワイヤ） — 東芝は、半導体の使用、または使用を検討中のユーザー向けに、半導体とストレージ製品の基礎知識や応用例についてのセミナー「ビギナーのための半導体講座」を、1月28日に神奈川県川崎市の東芝スマートコミュニティセンターで開催します。受講料は無料で、事前にホームページからの申し込みが必要となります。（定員50名） ■東芝半導体セミナー「ビギナーのための半導体講座」の概要...
View Article